GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25112
Submission : 2011-07-08
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31633
Submission : 2017-03-30
Status : Active
Type : IV

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42078
Submission : 2025-06-23
Status : Active
Type : IV

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF

NDC Package Code : 51552-0719
Start Marketing Date : 2012-01-02
End Marketing Date : 2026-07-16
Dosage Form (Strength) : POWDER (1g/g 1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING


FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25112
Submission : 2011-07-08
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31633
Submission : 2017-03-30
Status : Active
Type : IV

USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42078
Submission : 2025-06-23
Status : Active
Type : IV

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC Package Code : 51552-0719
Start Marketing Date : 2012-01-02
End Marketing Date : 2026-07-16
Dosage Form (Strength) : POWDER (1g/g 1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : HANGZHOU THINK CHEMICAL CO., LTD. (THINKCHEM) is an integrative corporation of trade, research and contract manufacture. With about ten years of business experiences on the marketi...

About the Company : HENGDIAN GROUP was established in 1975, till now it has become a transnational,conglomerate group and been one of the largest private-owned enterprises in China. The Pharmaceutical...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
Drug : SAPHRIS
Dosage Form : TABLET; SUBLINGUAL
Application Number : 22117
Country : US
Patented : Yes
Drug : NITROFURANTOIN
Dosage Form : SUSPENSION; ORAL
Application Number : 201355
Country : US
Patented : No
OMEPRAZOLE; SODIUM BICARBONATE
Drug : OMEPRAZOLE AND SODIUM BICARBONATE
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 79182
Country : US
Patented : No
Drug : LEVETIRACETAM
Dosage Form : SOLUTION; ORAL
Application Number : 78582
Country : US
Patented : No
Drug : PROMETHAZINE HYDROCHLORIDE
Dosage Form : SYRUP; ORAL
Application Number : 40891
Country : US
Patented : No
Drug : VALGANCICLOVIR HYDROCHLORIDE
Dosage Form : FOR SOLUTION; ORAL
Application Number : 213306
Country : US
Patented : No
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Drug : BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form : TABLET; SUBLINGUAL
Application Number : 91422
Country : US
Patented : No

ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
Drug : MINASTRIN 24 FE
Dosage Form : TABLET; ORAL
Application Number : 203667
Country : US
Patented : No

Drug : RANITIDINE HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 207578
Country : US
Patented : No

IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE
Drug : ADVIL CONGESTION RELIEF
Dosage Form : TABLET; ORAL
Application Number : 22565
Country : US
Patented : No

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SUCRALOSE
Route : BUCCAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 3.5
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : NASAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 0.15
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : NASAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 0.15
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 5.5
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 5.4
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 2.33
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 1
Potency Unit : MG/1ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 1210
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 90
Potency Unit : MG/1PKT

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SUCRALOSE
Route : ORAL
CAS : 56038-13-2
UNII : 96K6UQ3ZD4
Potency Amount : 34.25
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES